Symptom-Based Markers for COVID-19 Transmission
Contact Network Transmission Modeling of Healthcare Associated Infections: Symptom-Based Markers for COVID-19 Transmission
1 other identifier
observational
214
1 country
1
Brief Summary
In this study, COVID-19 positive patients will be added to a bidirectional texting program to receive daily surveys about their symptoms with the infection. This data will further the understanding of COVID-19 symptom development throughout the infection period, as well as how those symptoms vary at different points of the day. This study will be a single cohort, observational study of COVID-19 patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Dec 2020
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 10, 2020
CompletedFirst Posted
Study publicly available on registry
December 11, 2020
CompletedStudy Start
First participant enrolled
December 15, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 19, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
May 19, 2021
CompletedResults Posted
Study results publicly available
January 26, 2026
CompletedJanuary 26, 2026
January 1, 2026
5 months
December 10, 2020
January 8, 2026
January 8, 2026
Conditions
Outcome Measures
Primary Outcomes (2)
Body Temperature
Body temperature taken each morning and evening throughout COVID-19 infection period.
10 days
COVID-19 Symptoms
Any symptoms experienced throughout COVID-19 infection period (aches, cough, decreased sense of taste and/or smell, diarrhea, difficulty breathing, headache, nausea, runny nose, sore throat, shortness of breath).
10 days
Study Arms (1)
COVID-19 Positive Patients
The study only includes one cohort: COVID-19 positive patients. Enrollees will not receive any therapeutic intervention; participants will simply report their temperature and any symptoms experienced twice per day for 10 days.
Eligibility Criteria
The study population will include patients at the University of Iowa Hospitals \& Clinics (UIHC). Approximately 5,000 people have already tested positive for COVID-19 in Johnson County alone, and numbers are continuing to increase. The University of Iowa Hospitals \& Clinics see many patients from outside of Johnson County as well.
You may qualify if:
- Fluent in English
- Tested positive for COVID-19
You may not qualify if:
- Prisoners
- Unable to provide own informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Iowa Hospitals & Clinics
Iowa City, Iowa, 52242, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Shelby Francis
- Organization
- University of Iowa
Study Officials
- PRINCIPAL INVESTIGATOR
Alberto M Segre, PhD
University of Iowa
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor, Chair, Department of Computer Science
Study Record Dates
First Submitted
December 10, 2020
First Posted
December 11, 2020
Study Start
December 15, 2020
Primary Completion
May 19, 2021
Study Completion
May 19, 2021
Last Updated
January 26, 2026
Results First Posted
January 26, 2026
Record last verified: 2026-01